Position paper Statin intolerance – an attempt at a unified definition. Position paper from an International Lipid Expert PanelMaciej Banach, Dimitri P. Mikhailidis, Wilbert S. Aronow et al.|Archives of Medical Science|2015Cited by 383
Current practice in identifying and treating cardiovascular risk, with a focus on residual risk associated with atherogenic dyslipidaemiaRoberto Ferrari, Alberico L. Catapano, Carlos Aguíar et al.|European Heart Journal Supplements|2016Cited by 101
A review of the evidence on reducing macrovascular risk in patients with atherogenic dyslipidaemia: A report from an expert consensus meeting on the role of fenofibrate–statin combination therapyCarlos Aguíar, Roberto Ferrari, Eduardo Alegría et al.|Atherosclerosis Supplements|2015Cited by 84